-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Accelerate Diagnostics, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q2 2024.
- Accelerate Diagnostics, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 23.1M shares, a 109% increase year-over-year.
- Accelerate Diagnostics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 12.5M shares, a 51.9% increase from 2022.
- Accelerate Diagnostics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8.22M shares, a 33.1% increase from 2021.
- Accelerate Diagnostics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 6.17M shares, a 89% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)